Brain diseases a part of central nervous system diseases, is a condition where the brain structure or functions alter. The brain diseases include conditions or disabilities that affect the brain. Mostly brain disorders occur due to traumatic injury, genetic or other diseases, while a small number of brain diseases occur due to environmental factors. The major concerned brain disease are caused due to brain deterioration which may lead to neurodegenerative diseases such as Alzheimer’s, Huntington’s disease, and others. The mental disorders or mental illness occurrence is also related to the brain diseases, which include depression, anxiety, bipolar disorders, and others. The etiology of brain disease is not specific. It can occur to anyone and the risk factors of brain diseases differ in accordance to the different types of brain diseases. The sign and symptoms also differ for every brain diseases. Some of the most common symptoms include headache, memory loss, tremors, increased reflexes, slurred speech, paralysis, and inability to concentrate among others. Moreover, the treatment of brain diseases range from surgery to rehabilitation to medications; depending upon the brain disease the patient is affected by. The brain diseases are progressive which may affect the daily life of patients and hence should be immediately treated upon their diagnosis or detection.
The incidence and prevalence of brain diseases and disorders increase with age. The growing baby booming population is the major factor driving the brain disease market, globally. Rising prevalence of brain diseases is expected to boost the growth of the market. Due lack of effective treatment for some brain diseases such as brain cancer, they are a huge demand for medicinal treatment. Because of this reason, key market players are intensively focusing on R&D to develop a safe and effective treatment for brain diseases. All these factors act as driver for burgeoning growth of the brain disease market. However, adverse effects associated with the medications of brain diseases is anticipated to hinder the market growth.
Market Analysis and Insights: Global Brain Disease Market
The global Brain Disease market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.
Global Brain Disease Scope and Market Size
Brain Disease market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Brain Disease market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
The following players are covered in this report:
Pfizer
Eli Lilly
F. Hoffmann La Roche
GE Healthcare
Janssen Pharmaceuticals
Abbvie
AC Immune
Allergan
Merck
Novartis
AstraZeneca
Brain Disease Breakdown Data by Type
Brain Cancer
Alzheimer Disease
Alcoholism
Amnesia
Epilepsy
Meningitis
Others
Brain Disease Breakdown Data by Application
Hospitals Pharmacy
Online Pharmacy
Pharmacy
The incidence and prevalence of brain diseases and disorders increase with age. The growing baby booming population is the major factor driving the brain disease market, globally. Rising prevalence of brain diseases is expected to boost the growth of the market. Due lack of effective treatment for some brain diseases such as brain cancer, they are a huge demand for medicinal treatment. Because of this reason, key market players are intensively focusing on R&D to develop a safe and effective treatment for brain diseases. All these factors act as driver for burgeoning growth of the brain disease market. However, adverse effects associated with the medications of brain diseases is anticipated to hinder the market growth.
Market Analysis and Insights: Global Brain Disease Market
The global Brain Disease market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.
Global Brain Disease Scope and Market Size
Brain Disease market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Brain Disease market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
The following players are covered in this report:
Pfizer
Eli Lilly
F. Hoffmann La Roche
GE Healthcare
Janssen Pharmaceuticals
Abbvie
AC Immune
Allergan
Merck
Novartis
AstraZeneca
Brain Disease Breakdown Data by Type
Brain Cancer
Alzheimer Disease
Alcoholism
Amnesia
Epilepsy
Meningitis
Others
Brain Disease Breakdown Data by Application
Hospitals Pharmacy
Online Pharmacy
Pharmacy
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Brain Disease Revenue
1.4 Market by Type
1.4.1 Global Brain Disease Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Brain Cancer
1.4.3 Alzheimer Disease
1.4.4 Alcoholism
1.4.5 Amnesia
1.4.6 Epilepsy
1.4.7 Meningitis
1.4.8 Others
1.5 Market by Application
1.5.1 Global Brain Disease Market Share by Application: 2020 VS 2026
1.5.2 Hospitals Pharmacy
1.5.3 Online Pharmacy
1.5.4 Pharmacy
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Global Brain Disease Market Perspective (2015-2026)
2.2 Global Brain Disease Growth Trends by Regions
2.2.1 Brain Disease Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Brain Disease Historic Market Share by Regions (2015-2020)
2.2.3 Brain Disease Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Brain Disease Market Growth Strategy
2.3.6 Primary Interviews with Key Brain Disease Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top Brain Disease Players by Market Size
3.1.1 Global Top Brain Disease Players by Revenue (2015-2020)
3.1.2 Global Brain Disease Revenue Market Share by Players (2015-2020)
3.1.3 Global Brain Disease Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Brain Disease Market Concentration Ratio
3.2.1 Global Brain Disease Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Brain Disease Revenue in 2019
3.3 Brain Disease Key Players Head office and Area Served
3.4 Key Players Brain Disease Product Solution and Service
3.5 Date of Enter into Brain Disease Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Brain Disease Historic Market Size by Type (2015-2020)
4.2 Global Brain Disease Forecasted Market Size by Type (2021-2026)
5 Market Size by Application (2015-2026)
5.1 Global Brain Disease Market Size by Application (2015-2020)
5.2 Global Brain Disease Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Brain Disease Market Size (2015-2020)
6.2 Brain Disease Key Players in North America (2019-2020)
6.3 North America Brain Disease Market Size by Type (2015-2020)
6.4 North America Brain Disease Market Size by Application (2015-2020)
7 Europe
7.1 Europe Brain Disease Market Size (2015-2020)
7.2 Brain Disease Key Players in Europe (2019-2020)
7.3 Europe Brain Disease Market Size by Type (2015-2020)
7.4 Europe Brain Disease Market Size by Application (2015-2020)
8 China
8.1 China Brain Disease Market Size (2015-2020)
8.2 Brain Disease Key Players in China (2019-2020)
8.3 China Brain Disease Market Size by Type (2015-2020)
8.4 China Brain Disease Market Size by Application (2015-2020)
9 Japan
9.1 Japan Brain Disease Market Size (2015-2020)
9.2 Brain Disease Key Players in Japan (2019-2020)
9.3 Japan Brain Disease Market Size by Type (2015-2020)
9.4 Japan Brain Disease Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia Brain Disease Market Size (2015-2020)
10.2 Brain Disease Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Brain Disease Market Size by Type (2015-2020)
10.4 Southeast Asia Brain Disease Market Size by Application (2015-2020)
11 India
11.1 India Brain Disease Market Size (2015-2020)
11.2 Brain Disease Key Players in India (2019-2020)
11.3 India Brain Disease Market Size by Type (2015-2020)
11.4 India Brain Disease Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America Brain Disease Market Size (2015-2020)
12.2 Brain Disease Key Players in Central & South America (2019-2020)
12.3 Central & South America Brain Disease Market Size by Type (2015-2020)
12.4 Central & South America Brain Disease Market Size by Application (2015-2020)
13 Key Players Profiles
13.1 Pfizer
13.1.1 Pfizer Company Details
13.1.2 Pfizer Business Overview
13.1.3 Pfizer Brain Disease Introduction
13.1.4 Pfizer Revenue in Brain Disease Business (2015-2020))
13.1.5 Pfizer Recent Development
13.2 Eli Lilly
13.2.1 Eli Lilly Company Details
13.2.2 Eli Lilly Business Overview
13.2.3 Eli Lilly Brain Disease Introduction
13.2.4 Eli Lilly Revenue in Brain Disease Business (2015-2020)
13.2.5 Eli Lilly Recent Development
13.3 F. Hoffmann La Roche
13.3.1 F. Hoffmann La Roche Company Details
13.3.2 F. Hoffmann La Roche Business Overview
13.3.3 F. Hoffmann La Roche Brain Disease Introduction
13.3.4 F. Hoffmann La Roche Revenue in Brain Disease Business (2015-2020)
13.3.5 F. Hoffmann La Roche Recent Development
13.4 GE Healthcare
13.4.1 GE Healthcare Company Details
13.4.2 GE Healthcare Business Overview
13.4.3 GE Healthcare Brain Disease Introduction
13.4.4 GE Healthcare Revenue in Brain Disease Business (2015-2020)
13.4.5 GE Healthcare Recent Development
13.5 Janssen Pharmaceuticals
13.5.1 Janssen Pharmaceuticals Company Details
13.5.2 Janssen Pharmaceuticals Business Overview
13.5.3 Janssen Pharmaceuticals Brain Disease Introduction
13.5.4 Janssen Pharmaceuticals Revenue in Brain Disease Business (2015-2020)
13.5.5 Janssen Pharmaceuticals Recent Development
13.6 Abbvie
13.6.1 Abbvie Company Details
13.6.2 Abbvie Business Overview
13.6.3 Abbvie Brain Disease Introduction
13.6.4 Abbvie Revenue in Brain Disease Business (2015-2020)
13.6.5 Abbvie Recent Development
13.7 AC Immune
13.7.1 AC Immune Company Details
13.7.2 AC Immune Business Overview
13.7.3 AC Immune Brain Disease Introduction
13.7.4 AC Immune Revenue in Brain Disease Business (2015-2020)
13.7.5 AC Immune Recent Development
13.8 Allergan
13.8.1 Allergan Company Details
13.8.2 Allergan Business Overview
13.8.3 Allergan Brain Disease Introduction
13.8.4 Allergan Revenue in Brain Disease Business (2015-2020)
13.8.5 Allergan Recent Development
13.9 Merck
13.9.1 Merck Company Details
13.9.2 Merck Business Overview
13.9.3 Merck Brain Disease Introduction
13.9.4 Merck Revenue in Brain Disease Business (2015-2020)
13.9.5 Merck Recent Development
13.10 Novartis
13.10.1 Novartis Company Details
13.10.2 Novartis Business Overview
13.10.3 Novartis Brain Disease Introduction
13.10.4 Novartis Revenue in Brain Disease Business (2015-2020)
13.10.5 Novartis Recent Development
13.11 AstraZeneca
10.11.1 AstraZeneca Company Details
10.11.2 AstraZeneca Business Overview
10.11.3 AstraZeneca Brain Disease Introduction
10.11.4 AstraZeneca Revenue in Brain Disease Business (2015-2020)
10.11.5 AstraZeneca Recent Development
14 Analyst's Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Brain Disease Revenue
1.4 Market by Type
1.4.1 Global Brain Disease Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Brain Cancer
1.4.3 Alzheimer Disease
1.4.4 Alcoholism
1.4.5 Amnesia
1.4.6 Epilepsy
1.4.7 Meningitis
1.4.8 Others
1.5 Market by Application
1.5.1 Global Brain Disease Market Share by Application: 2020 VS 2026
1.5.2 Hospitals Pharmacy
1.5.3 Online Pharmacy
1.5.4 Pharmacy
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Global Brain Disease Market Perspective (2015-2026)
2.2 Global Brain Disease Growth Trends by Regions
2.2.1 Brain Disease Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Brain Disease Historic Market Share by Regions (2015-2020)
2.2.3 Brain Disease Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Brain Disease Market Growth Strategy
2.3.6 Primary Interviews with Key Brain Disease Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top Brain Disease Players by Market Size
3.1.1 Global Top Brain Disease Players by Revenue (2015-2020)
3.1.2 Global Brain Disease Revenue Market Share by Players (2015-2020)
3.1.3 Global Brain Disease Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Brain Disease Market Concentration Ratio
3.2.1 Global Brain Disease Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Brain Disease Revenue in 2019
3.3 Brain Disease Key Players Head office and Area Served
3.4 Key Players Brain Disease Product Solution and Service
3.5 Date of Enter into Brain Disease Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Brain Disease Historic Market Size by Type (2015-2020)
4.2 Global Brain Disease Forecasted Market Size by Type (2021-2026)
5 Market Size by Application (2015-2026)
5.1 Global Brain Disease Market Size by Application (2015-2020)
5.2 Global Brain Disease Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Brain Disease Market Size (2015-2020)
6.2 Brain Disease Key Players in North America (2019-2020)
6.3 North America Brain Disease Market Size by Type (2015-2020)
6.4 North America Brain Disease Market Size by Application (2015-2020)
7 Europe
7.1 Europe Brain Disease Market Size (2015-2020)
7.2 Brain Disease Key Players in Europe (2019-2020)
7.3 Europe Brain Disease Market Size by Type (2015-2020)
7.4 Europe Brain Disease Market Size by Application (2015-2020)
8 China
8.1 China Brain Disease Market Size (2015-2020)
8.2 Brain Disease Key Players in China (2019-2020)
8.3 China Brain Disease Market Size by Type (2015-2020)
8.4 China Brain Disease Market Size by Application (2015-2020)
9 Japan
9.1 Japan Brain Disease Market Size (2015-2020)
9.2 Brain Disease Key Players in Japan (2019-2020)
9.3 Japan Brain Disease Market Size by Type (2015-2020)
9.4 Japan Brain Disease Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia Brain Disease Market Size (2015-2020)
10.2 Brain Disease Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Brain Disease Market Size by Type (2015-2020)
10.4 Southeast Asia Brain Disease Market Size by Application (2015-2020)
11 India
11.1 India Brain Disease Market Size (2015-2020)
11.2 Brain Disease Key Players in India (2019-2020)
11.3 India Brain Disease Market Size by Type (2015-2020)
11.4 India Brain Disease Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America Brain Disease Market Size (2015-2020)
12.2 Brain Disease Key Players in Central & South America (2019-2020)
12.3 Central & South America Brain Disease Market Size by Type (2015-2020)
12.4 Central & South America Brain Disease Market Size by Application (2015-2020)
13 Key Players Profiles
13.1 Pfizer
13.1.1 Pfizer Company Details
13.1.2 Pfizer Business Overview
13.1.3 Pfizer Brain Disease Introduction
13.1.4 Pfizer Revenue in Brain Disease Business (2015-2020))
13.1.5 Pfizer Recent Development
13.2 Eli Lilly
13.2.1 Eli Lilly Company Details
13.2.2 Eli Lilly Business Overview
13.2.3 Eli Lilly Brain Disease Introduction
13.2.4 Eli Lilly Revenue in Brain Disease Business (2015-2020)
13.2.5 Eli Lilly Recent Development
13.3 F. Hoffmann La Roche
13.3.1 F. Hoffmann La Roche Company Details
13.3.2 F. Hoffmann La Roche Business Overview
13.3.3 F. Hoffmann La Roche Brain Disease Introduction
13.3.4 F. Hoffmann La Roche Revenue in Brain Disease Business (2015-2020)
13.3.5 F. Hoffmann La Roche Recent Development
13.4 GE Healthcare
13.4.1 GE Healthcare Company Details
13.4.2 GE Healthcare Business Overview
13.4.3 GE Healthcare Brain Disease Introduction
13.4.4 GE Healthcare Revenue in Brain Disease Business (2015-2020)
13.4.5 GE Healthcare Recent Development
13.5 Janssen Pharmaceuticals
13.5.1 Janssen Pharmaceuticals Company Details
13.5.2 Janssen Pharmaceuticals Business Overview
13.5.3 Janssen Pharmaceuticals Brain Disease Introduction
13.5.4 Janssen Pharmaceuticals Revenue in Brain Disease Business (2015-2020)
13.5.5 Janssen Pharmaceuticals Recent Development
13.6 Abbvie
13.6.1 Abbvie Company Details
13.6.2 Abbvie Business Overview
13.6.3 Abbvie Brain Disease Introduction
13.6.4 Abbvie Revenue in Brain Disease Business (2015-2020)
13.6.5 Abbvie Recent Development
13.7 AC Immune
13.7.1 AC Immune Company Details
13.7.2 AC Immune Business Overview
13.7.3 AC Immune Brain Disease Introduction
13.7.4 AC Immune Revenue in Brain Disease Business (2015-2020)
13.7.5 AC Immune Recent Development
13.8 Allergan
13.8.1 Allergan Company Details
13.8.2 Allergan Business Overview
13.8.3 Allergan Brain Disease Introduction
13.8.4 Allergan Revenue in Brain Disease Business (2015-2020)
13.8.5 Allergan Recent Development
13.9 Merck
13.9.1 Merck Company Details
13.9.2 Merck Business Overview
13.9.3 Merck Brain Disease Introduction
13.9.4 Merck Revenue in Brain Disease Business (2015-2020)
13.9.5 Merck Recent Development
13.10 Novartis
13.10.1 Novartis Company Details
13.10.2 Novartis Business Overview
13.10.3 Novartis Brain Disease Introduction
13.10.4 Novartis Revenue in Brain Disease Business (2015-2020)
13.10.5 Novartis Recent Development
13.11 AstraZeneca
10.11.1 AstraZeneca Company Details
10.11.2 AstraZeneca Business Overview
10.11.3 AstraZeneca Brain Disease Introduction
10.11.4 AstraZeneca Revenue in Brain Disease Business (2015-2020)
10.11.5 AstraZeneca Recent Development
14 Analyst's Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
